Terms: = Ovarian cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Diagnosis
411 results:
1. cancer Risks Associated With
Fortuno C; Feng BJ; Carroll C; Innella G; Kohlmann W; Lázaro C; Brunet J; Feliubadaló L; Iglesias S; Menéndez M; Teulé A; Ballinger ML; Thomas DM; Campbell A; Field M; Harris M; Kirk J; Pachter N; Poplawski N; Susman R; Tucker K; Wallis M; Williams R; Cops E; Goldgar D; ; James PA; Spurdle AB
JCO Precis Oncol; 2024 Feb; 8():e2300453. PubMed ID: 38412388
[TBL] [Abstract] [Full Text] [Related]
2. To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma.
Yadav A; Sistla A; Swain M; Gowrishankar S; Padua M; Modi T; Himabindu R; Agarwal N; Kulkarni A; Bhandari T; Vudayaraju H; Chinnababu ; Reddy VA
Indian J Pathol Microbiol; 2024; 67(1):62-67. PubMed ID: 38358190
[TBL] [Abstract] [Full Text] [Related]
3. Phenotype analysis of families with tp53 germline variants at the Center for Familial Breast and ovarian cancer, Cologne.
Kast K; Rhiem K; Larsen M; Wappenschmidt B; Schmutzler R
Cancer Med; 2024 Feb; 13(3):e6920. PubMed ID: 38230850
[TBL] [Abstract] [Full Text] [Related]
4. Role of SLC7A11/xCT in ovarian cancer.
Fantone S; Piani F; Olivieri F; Rippo MR; Sirico A; Di Simone N; Marzioni D; Tossetta G
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203758
[TBL] [Abstract] [Full Text] [Related]
5. Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Young Han C; Bedia JS; Yang WL; Hawley SJ; Bergan L; Hopper M; Celestino J; Guo J; Gornet TG; Soosaipillai A; Yang H; Doskocil SD; Lokshin AE; Handy BC; Diamandis EP; Moore RG; Lu KH; Lu Z; Anderson KS; Drescher CW; Skates SJ; Bast RC
Br J Cancer; 2024 Mar; 130(5):861-868. PubMed ID: 38195887
[TBL] [Abstract] [Full Text] [Related]
6. Identifying Explainable Machine Learning Models and a Novel SFRP2
Yang Z; Zhou D; Huang J
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069266
[TBL] [Abstract] [Full Text] [Related]
7. Genomic instability analysis in DNA from Papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer.
Paracchini L; Mannarino L; Romualdi C; Zadro R; Beltrame L; Fuso Nerini I; Zola P; Laudani ME; Pagano E; Giordano L; Fruscio R; Landoni F; Franceschi S; Dalessandro ML; Canzonieri V; Bocciolone L; Lorusso D; Bosetti C; Raspagliesi F; Garassino IMG; ; D'Incalci M; Marchini S
Sci Transl Med; 2023 Dec; 15(725):eadi2556. PubMed ID: 38055801
[TBL] [Abstract] [Full Text] [Related]
8. Aneuploidy Landscape in Precursors of ovarian cancer.
Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM
Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050
[TBL] [Abstract] [Full Text] [Related]
9. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in ovarian cancer.
Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
[TBL] [Abstract] [Full Text] [Related]
10. Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With ovarian cancer.
Dobilas A; Chen Y; Brueffer C; Leandersson P; Saal LH; Borgfeldt C
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):763-770. PubMed ID: 38035709
[TBL] [Abstract] [Full Text] [Related]
11. Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo.
Pereira M; Glogova A; Haagsma J; Stewart J; Shepherd TG; Petrik J
J Ovarian Res; 2023 Nov; 16(1):218. PubMed ID: 37986175
[TBL] [Abstract] [Full Text] [Related]
12. Frontiers of ovarian Carcinosarcoma.
Ismail A; Choi S; Boussios S
Curr Treat Options Oncol; 2023 Dec; 24(12):1667-1682. PubMed ID: 37938504
[TBL] [Abstract] [Full Text] [Related]
13. cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.
Vylegzhanina AV; Bespalov IA; Novototskaya-Vlasova KA; Hall BM; Gleiberman AS; Yu H; Leontieva OV; Leonova KI; Kurnasov OV; Osterman AL; Dy GK; Komissarov AA; Vasilieva E; Gehlhausen J; Iwasaki A; Ambrosone CB; Tsuji T; Matsuzaki J; Odunsi K; Andrianova EL; Gudkov AV
Cancer Res Commun; 2023 Nov; 3(11):2256-2267. PubMed ID: 37870410
[TBL] [Abstract] [Full Text] [Related]
14. Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instability.
Nelson L; Barnes BM; Tighe A; Littler S; Coulson-Gilmer C; Golder A; Desai S; Morgan RD; McGrail JC; Taylor SS
Chromosome Res; 2023 Aug; 31(3):21. PubMed ID: 37592171
[TBL] [Abstract] [Full Text] [Related]
15. Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing.
Deng L; Zeng J; Qiu JF; Yang LH; Ma J
Medicine (Baltimore); 2023 Aug; 102(32):e34523. PubMed ID: 37565864
[TBL] [Abstract] [Full Text] [Related]
16. Clinical Features of Li-Fraumeni Syndrome in Korea.
Song R; Kong SY; Choi W; Lee EG; Woo J; Han JH; Lee S; Kang HS; Jung SY
Cancer Res Treat; 2024 Jan; 56(1):334-341. PubMed ID: 37562436
[TBL] [Abstract] [Full Text] [Related]
17. The success rates of clinical cancer next-generation sequencing based on pathologic diagnosis: Experience from a single academic laboratory.
Latham K; Dong F
Am J Clin Pathol; 2023 Nov; 160(5):533-539. PubMed ID: 37543867
[TBL] [Abstract] [Full Text] [Related]
18. High-grade Serous Carcinoma can Show Squamoid Morphology Mimicking True Squamous Differentiation.
Tomonobe H; Ohishi Y; Hachisuga K; Yahata H; Kato K; Oda Y
Am J Surg Pathol; 2023 Sep; 47(9):967-976. PubMed ID: 37382102
[TBL] [Abstract] [Full Text] [Related]
19. "Surface epithelial slackening" pattern in endometrioid carcinoma: A morphological feature for differentiating the POLE mutation-subtype from the no specific molecular profile subtype.
Kitazono I; Akahane T; Yokoyama S; Kobayashi Y; Togami S; Yanazume S; Tasaki T; Noguchi H; Tabata K; Kobayashi H; Tanimoto A
Pathol Res Pract; 2023 Jul; 247():154563. PubMed ID: 37229919
[TBL] [Abstract] [Full Text] [Related]
20. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma].
Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628
[No Abstract] [Full Text] [Related]
[Next]
